Diversified Trust CO Glycomimetics Inc Transaction History

Diversified Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 20, 2021	SELL	$2.16 - $3.18 $30,078 - $44,281	-13,925 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$2.89 - $4.22 $4,207 - $6,144	-1,456 Reduced 9.47%	13,925 $42,000
Q4 2020 Jan 08, 2021	SELL	$2.69 - $4.24 $379 - $597	-141 Reduced 0.91%	15,381 $58,000
Q2 2020 Jul 07, 2020	BUY	$2.06 - $3.76 $31,975 - $58,362	15,522 New	15,522 $58,000

36.8M

969K

636K

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $14.7M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.